Liminatus Pharma Inc. Class A Common Stock

LIMN | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.07

+$0.43 (+11.81%)

At close: Sep 22, 2026, 4:00 PM ET

$4.09

+$0.02 (+0.49%)

After-hours: Sep 22, 2026, 7:50 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $4.89M

Enterprise Value $3.31M

Beta 0.71

Average Volume 578.8K

Shares Outstanding (Diluted) 967.97K

Shares Change YoY 107.71%

Institutional Ownership 6.21%

Exchange NASDAQ

ISIN US53271X2071

Price Performance

Price Change 1M -27.2%

Price Change 3M -34.4%

Price Change 6M -62.8%

Price Change YTD -88.6%

Price Change 1Y -94.9%

Price Change 3Y -99.1%

Price Change 5Y -99.1%

1M CAGR (ann.) -29.3%

1Y CAGR (ann.) -94.4%

5Y CAGR (ann.) N/A

All-Time CAGR -95.1%

Valuation

PE Ratio -0.16

Forward PE N/A

PEG Ratio -0.00

Forward PEG -0.00

PS Ratio N/A

Forward PS N/A

PB Ratio 16.26

P/FCF Ratio -1.23

P/Adj. FCF Ratio -1.23

P/OCF Ratio -0.44

EV/Sales N/A

EV/EBIT -0.27

EV/EBITDA -0.27

EV/FCF -0.83

Earnings Yield -609.6%

FCF Yield -81.5%

Adj. FCF Yield -81.5%

Financial Health

Net Cash $1.57M

Total Debt $1.44M

Cash & Short-Term Investments $3.02M

Total Assets $3.4M

Current Ratio 1.12

Quick Ratio 1.12

Debt / Equity Ratio 4.80

Debt / EBITDA -0.12

Debt / FCF -0.36

OCF / Debt -2.75

Interest Coverage -53.78

Altman Z-Score -28.02

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -367.9%

Return on Equity 443.6%

Return on Invested Capital -225.1%

Return on Capital Employed -1119.0%

Return on Tangible Assets -367.9%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -42.9%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -60.5%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Aug 13, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-3.97M

Free Cash Flow $-3.99M

Adj. Free Cash Flow $-3.99M

FCF Per Share -$8.39

OCF Per Share -$8.36

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-986

Operating Income $-4.07M

EBITDA $-12.44M

Net Income $-12.52M

EPS (Diluted) -$22.19

Revenue / Employee N/A

Profit / Employee $-12.52M

Employees 1